The use of epoetin alfa to increase and maintain hemoglobin levels during radiotherapy

Seminars in Oncology

Volumn 28, Issue 2 SUPPL. 8, 2001, Pages 42-48

  Dunst, Jürgen ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; HEMOGLOBIN DETERMINATION; HUMAN; HYPOXIA; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS;

EID: 0034994667     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/sonc.2001.25395     Document Type: Article

References (25)

1. Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by RT: Results of a retrospective study of 386 patients
2. Significance of hemoglobin concentrations for treatment outcome
3. The prognostic value of hemoglobin and a decrease in hemoglobin during radiotherapy in laryngeal carcinoma
4. Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx
5. Prognostic value of hemoglobin concentration in radiotherapy for cancer of supraglottic larynx
6. The impact of blood hemoglobin content on the outcome of radiotherapy. The Freiburg experience
7. R-Hu-erythropoietin supply increases efficacy of neoadjuvant radio-chemotherapy in patients with oral squamous cell carcinoma
8. Tumor hypoxia in pelvic recurrences of cervical cancer
9. Anemia is associated with decreased survival and increased locoregional failures in patients with locally advanced head and neck carcinoma: A secondary analysis of RTOG 85-27
10. Influence of the hypoxic subvolume on the survival of patients with head and neck cancer
11. Oxygenation of human tumors: The Mainz experience
12. Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas
13. Vascular endothelial growth factor (VEGF) in sera and plasma of tumor patients and the impact of hemoglobin
14. Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: Report from the DAHANCA 2 study
15. T1/T2 glottic cancer managed by external beam radiotherapy: The influence of pretreatment hemoglobin on local control
16. Clinical radiobiology of glottic T1 squamous cell carcinoma
17. Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: A prospective study
18. R-HuErythropoietin treatment increases efficacy of neoadjuvant radiochemotherapy and improves cancer free survival of patients with oral squamous cell carcinoma: A 17 month follow up
19. Prognostic value of hemoglobin concentrations in patients with advanced head and neck cancer treated with combined radio-chemotherapy and surgery
20. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix
21. Radiotherapy-associated anemia: The scope of the problem
22. Clinical trial experience using erythropoietin during radiation therapy
23. Erythropoietin increases hemoglobin during radiation therapy for cervical cancer
24. The effect of systematic rHu-erythropoietin (epoetin alfa) treatment before and during radiotherapy (radio-chemotherapy) in unselected anemic cancer patients: Results of an Austrian multicenter observation study
25. Effect of the administration of recombinant human erythropoietin in patients with pelvic malignancies during radiotherapy